XPH
XPH
About State Street SPDR S&P Pharmaceuticals ETF
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks...
About State Street SPDR S&P Pharmaceuticals ETF
SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 CRNX | Crinetics Pharmaceuticals, Inc. | 3.75% | 206.82K | $17.30M |
 MBX | MBX Biosciences, Inc. Common Stock | 2.98% | 229.04K | $13.75M |
 DFTX | Definium Therapeutics, Inc. | 2.89% | 305.42K | $13.33M |
 ALMS | Alumis Inc. | 2.15% | 353.84K | $9.94M |
 ELVN | Enliven Therapeutics, Inc. | 2.11% | 191.84K | $9.76M |
 ATAI | Atai Beckley Inc. | 2.02% | 1.88M | $9.33M |
 AMLX | Amylyx Pharmaceuticals, Inc. | 1.99% | 527.34K | $9.18M |
 NUVB | Nuvation Bio Inc. | 1.94% | 1.55M | $8.94M |
 EWTX | Edgewise Therapeutics, Inc. | 1.93% | 215.61K | $8.90M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.91% | 28.59K | $8.84M |
 TRVI | Trevi Therapeutics, Inc. | 1.89% | 529.70K | $8.75M |
 NKTR | Nektar Therapeutics | 1.85% | 125.01K | $8.54M |
 MAZE | Maze Therapeutics, Inc. | 1.82% | 288.61K | $8.42M |
 MANE | Veradermics, Incorporated | 1.82% | 76.34K | $8.41M |
 HROW | Harrow Health, Inc. | 1.79% | 197.72K | $8.27M |
 EYPT | EyePoint Pharmaceuticals, Inc. | 1.78% | 575.67K | $8.22M |
 OCUL | Ocular Therapeutix, Inc. | 1.74% | 812.13K | $8.02M |
 AMRX | Amneal Pharmaceuticals, Inc. | 1.72% | 463.32K | $7.96M |
 CORT | Corcept Therapeutics Incorporated | 1.69% | 90.86K | $7.80M |
 ELAN | Elanco Animal Health Incorporated | 1.69% | 310.36K | $7.80M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland SingaporeHoldings (Top 20)
CRNX
Crinetics Pharmaceuticals, Inc.
MBX
MBX Biosciences, Inc. Common Stock
DFTX
Definium Therapeutics, Inc.
ALMS
Alumis Inc.
ELVN
Enliven Therapeutics, Inc.
ATAI
Atai Beckley Inc.
AMLX
Amylyx Pharmaceuticals, Inc.
NUVB
Nuvation Bio Inc.
EWTX
Edgewise Therapeutics, Inc.
LGND
Ligand Pharmaceuticals Incorporated
TRVI
Trevi Therapeutics, Inc.
NKTR
Nektar Therapeutics
MAZE
Maze Therapeutics, Inc.
MANE
Veradermics, Incorporated
HROW
Harrow Health, Inc.
EYPT
EyePoint Pharmaceuticals, Inc.
OCUL
Ocular Therapeutix, Inc.
AMRX
Amneal Pharmaceuticals, Inc.
CORT
Corcept Therapeutics Incorporated
ELAN
Elanco Animal Health Incorporated